If your genetic profile shows lower GLP-1 receptor sensitivity or variants associated with stronger hunger signals, you're likely among those who experience rapid rebound after discontinuation
Understanding semaglutide dosing is critical for patient safety and treatment success
other participants
Don and Jason are both in the growing population of riders who are benefiting from GLP-1 drugs like Ozempictheyre quick to note that these powerful peptides arent for everyone, but for those suffering from obesity-related health conditions, they can be a game changer, or even a lifesaver
Furthermore, the risks of myocardial infarction (HR 0.91, 95% CI 0.840.98 with GLP-1RAs and HR 0.89, 95% CI 0.800.98 with SGLT2is) and cardiovascular death (HR 0.88, 95% CI 0.800.96 with GLP-1RAs and HR 0.84, 95% CI 0.750.94 with SGLT2is) were similarly reduced in both GLP-1RA and SGLT2i groups, while the risk of stroke was reduced only with GLP-1RAs (HR 0.86, 95% CI 0.770.97 with GLP-1RAs and HR 0.97, 95% CI 0.861.10 with SGLT2is)